Inhoudsopgave:
This expert volume in the \u003ci\u003eDiagnostic Pathology \u003c/i\u003eseries is not only an \u003cb\u003eup-to-date, comprehensive diagnostic support tool\u003c/b\u003e for surgical pathologists, but also a valuable resource for all health care workers who provide care to patients with breast disease, including radiologists as well as surgical, medical, and radiation oncologists. An \u003cb\u003eexcellent point-of-care reference for practitioners at all levels of experience and training\u003c/b\u003e, the fourth edition of \u003ci\u003eDiagnostic Pathology: Breast, Fourth Edition \u003c/i\u003eprovides details on normal breast histology, information to assist in processing breast specimens, and multichapter sections on diagnostic patterns, benign lesions, carcinomas, predictive and prognostic factors, stromal lesions, inflammatory lesions, lymphomas, and hereditary breast disease. \u003cb\u003eRichly illustrated and easy to use\u003c/b\u003e, this volume is ideal as \u003cb\u003ea one-stop resource\u003c/b\u003e for day-to-day reference or as a reliable training resource.\u003cul\u003e\u003cli\u003eIncorporates the most \u003cb\u003eup-to-date scientific and technical knowledge\u003c/b\u003e, providing a comprehensive overview of all key issues relevant to today\u0026rsquo;s practice\u003c/li\u003e\u003cli\u003eEmphasizes the \u003cb\u003ecorrelation of pathologic lesions with findings on breast imaging\u003c/b\u003e and provides guidance on the interpretation of core needle biopsies\u003c/li\u003e\u003cli\u003eContains \u003cb\u003enew overview chapters\u003c/b\u003e that lay the groundwork for initial evaluation and assistance with differential diagnosis, as well as \u003cb\u003enew chapters\u003c/b\u003e on HER2-low breast carcinoma, immunohistochemical studies for diagnosis, proliferation, and more\u003c/li\u003e\u003cli\u003eProvides \u003cb\u003eimportant updates throughout\u003c/b\u003e, covering the evaluation of \u003ci\u003eESR1\u003c/i\u003e, \u003ci\u003ePIK3CA\u003c/i\u003e, \u003ci\u003eAKT\u003c/i\u003e, and \u003ci\u003eBRCA1\u003c/i\u003e mutations to guide therapy; tumor-infiltrating lymphocytes and PD-L1 for treatment planning; HER2-low assessment to determine eligibility for antibody-drug conjugates; and much more\u003c/li\u003e\u003cli\u003eFeatures \u003cb\u003enew animations \u003c/b\u003eand\u003cb\u003e new videos\u003c/b\u003e to assist in understanding three-dimensional anatomy, radiologic-pathologic correlation, the processing of breast specimens, and the gross identification of breast lesions\u003c/li\u003e\u003cli\u003eContains \u003cb\u003emore than 3,700 extensively annotated images\u003c/b\u003e, including gross pathology photographs, histopathology photomicrographs, a wide range of immunohistochemical stains, fluorescent in situ hybridization, breast-imaging studies, and full-color illustrations\u003c/li\u003e\u003cli\u003eEmploys consistently \u003cb\u003etemplated chapters, bulleted content, key facts, annotated images, and an extensive index\u003c/b\u003e for quick, expert reference at the point of care\u003c/li\u003e\u003c/ul\u003e |